Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Herceptin and Vinorelbine for HER2-Positive Metastatic Breast Cancer: A Phase II Study

Harold Burstein, Irene Kuter, Paul Richardson, Susana Campos, Leroy Parker, Ursula Matulonis, Lyndsay Harris, Judy Garber, Jerry Younger, Craig Bunnell, Lawrence Shulman, Eric Winer. Herceptin and Vinorelbine for HER2-Positive Metastatic Breast Cancer: A Phase II Study. Proc Am Soc Clin Oncol. 2000; 19(abstr 392).


Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.